Takashi Kanbayashi: Influence Statistics

Takashi Kanbayashi

Takashi Kanbayashi

International Institute for Integrative Sleep Medicine, University of Tsukuba, Tsukuba, Japan | International Institute for Integrative Sleep Medicine (WPI‐IIIS), University ...

Takashi Kanbayashi: Expert Impact

Concepts for which Takashi Kanbayashi has direct influence: Cerebrospinal fluid , Orexin neurons , Symptomatic narcolepsy , Idiopathic hypersomnia , Cognitive function , Orexin levels , Hypothalamic lesions .

Takashi Kanbayashi: KOL impact

Concepts related to the work of other authors for which for which Takashi Kanbayashi has influence: Sleep disorders , Neuromyelitis optica , Idiopathic hypersomnia , Multiple sclerosis , Narcolepsy cataplexy , Cerebrospinal fluid , Blood pressure .

KOL Resume for Takashi Kanbayashi

Year
2022

International Institute for Integrative Sleep Medicine, University of Tsukuba, Tsukuba, Japan

2021

International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba.

Akita University, Department of Neuropsychiatry, Akita-City, Akita, 010-8543, Japan

2020

International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki, Japan.

Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan

2019

International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Japan

2018

Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita City, Akita 010-8543, Japan,

Akita University Graduate School of Medicine, Akita, JAPAN

International Institute for Integrative Sleep Medicine (WPI‐IIIS), University of Tsukuba, Ibaraki, Japan

2017

International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba

Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita

2016

Department of Neuropsychiatry Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Okayama, Japan Department of Psychiatry Okayama Psychiatric Medical Center Okayama, Japan Department of Neuropsychiatry Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama, Japan Department of Neurology Kanazawa Medical University Ishikawa, Japan Department of Neuropsychiatry Akita University Akita, Japan Department of Neuropsychiatry Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama, Japan manabuta@cc.okayama-u.ac.jp Department of Neuropsychiatry Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Department of Psychiatry Okayama Psychiatric Medical Center Okayama, Japan

2015

Department of Neuropsychiatry, Akita University Graduate School of Medicine, 1-1-1, Hondo, 010-8543, Akita, Japan

2014

Department of Neuropsychiatry, Akita University, Akita, Japan

Psychiatry, Akita University Hospital; International Institute for Integrative Sleep Medicine, Tsukuba University.

2013

Department of Neuropsychiatry, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan

2012

Department of Neuropsychiatry, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan

2011

Department of Psychiatry, Akita University School of Medicine, Akita, Japan

2010

Department of Neuropsychiatry, Akita University School of Medicine

2009

Dept. of Psychiatry, Akita University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, 980-8574, Sendai, Japan

2008

Department of Neuropsychiatry, School of Medicine, Akita University, 1-1-1 Hondo, 010-8543, Akita City, Japan

2007

Akita University, School of Medicine, Department of Neuropsychiatry, 1-1-1 Hondo, Akita, Akita 0108543, Japan

2006

Department of Neuropsychiatry, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan

2004

From the Department of Pediatrics (Dr. Arii), Chiba Rosai Hospital, and Division of Neurology (Dr. Tanabe), Chiba Children’s Hospital, Departments of Neuropsychiatry (Drs. Kanbayashi, Mishima, Hishikawa, and Shimizu) and Pediatrics (Dr. Sawaishi), Akita University School of Medicine, Department of Pediatrics (Dr. Kimura), Akita Red Cross Hospital, and Department of Pediatrics (Dr. Watanabe), Akita Nakadori General Hospital, Japan; and Center for Narcolepsy (Dr. Nishino), Stanford University, Palo Alto, CA.

Department of Neuropsychiatry, Akita University, School of Medicine, Akita, Japan

2003

Department of Neuropsychiatry, Akita University School of Medicine, Akita

2002

Department of Neuropsychiatry, Akita University School of Medicine, Akita, Japan,

2001

Department of Pediatrics, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8345, Japan

2000

Sleep Research Center, Stanford University School of Medicine, Palo Alto, CA 94304, USA

Akita University School of Medicine, Akita 010, Japan

1997

Department of Neuropsychiatry, Akita University School of Medicine.

1996

Center For Narcolepsy Research Department of Psychiatry and Behavioral Sciences Stanford University School of Medicine 701 Welch Road, Suite 2226 Palo Alto, CA 94304, U.S.A

1994

Department of Neuropsychiatry, Akita University School of Medicine, 1-1-1 Hondo, Akita-City, Akita 010, Japan

Prominent publications by Takashi Kanbayashi

KOL-Index: 28254 . Human narcolepsy is a chronic sleep disorder affecting 1:2000 individuals. The disease is characterized by excessive daytime sleepiness, cataplexy and other abnormal manifestations of REM sleep, such as sleep paralysis and hypnagogic hallucinations. Recently, it was discovered that the pathophysiology of (idiopathic) narcolepsy-cataplexy is linked to hypocretin ligand deficiency in the ...
Known for Symptomatic Narcolepsy | Eds Cases | Hypocretin Ligand Deficiency | Vascular Disorders
KOL-Index: 12475 . Excessive daytime sleepiness has been widely accepted as a common problem not only in Parkinson's disease (PD) but also in other related disorders. Lowered excretion of orexin A (hypocretin 1) into the cerebrospinal fluid (CSF) is known to play a pathological role in narcolepsy and secondary hypersomnia due to hypothalamic dysfunction. Although the levels of CSF orexin in PD have been ...
Known for Orexin Levels | Lewy Bodies | Progressive Supranuclear | Corticobasal Degeneration
KOL-Index: 12153 . STUDY OBJECTIVES: To compare clinical, electrophysiologic, and biologic data in narcolepsy without cataplexy with low (≤ 110 pg/ml), intermediate (110-200 pg/ml), and normal (> 200 pg/ml) concentrations of cerebrospinal fluid (CSF) hypocretin-1. SETTING: University-based sleep clinics and laboratories. PATIENTS: Narcolepsy without cataplexy (n = 171) and control patients (n = 170), all ...
Known for Patients Narcolepsy | Csf Hypocretin1 | Sleep Onset | Cerebrospinal Fluid
KOL-Index: 10778 . STUDY OBJECTIVES: Sleep deprivation has a profound effect on cardiovascular regulation through the autonomic nervous system. This study examined the effect of 24-hour total sleep deprivation on muscle sympathetic nerve activity (MSNA), which is a direct measurement of the postganglionic sympathetic efferent innervating the vascular bed in the skeletal muscle and other circulatory ...
Known for Total Sleep Deprivation | Blood Pressure | Control Sleep | Burst Incidence
KOL-Index: 10735 . STUDY OBJECTIVE: To (1) replicate our prior result of low cerebrospinal fluid (CSF) histamine levels in human narcolepsy in a different sample population and to (2) evaluate if histamine contents are altered in other types of hypersomnia with and without hypocretin deficiency. DESIGN: Cross sectional studies. SETTING AND PATIENTS: Sixty-seven narcolepsy subjects, 26 idiopathic hypersomnia ...
Known for Idiopathic Hypersomnia | Csf Histamine | Sleep Apnea | Narcolepsy Cataplexy
KOL-Index: 8762 . Although an abnormally low cerebrospinal fluid (CSF)-orexin level is well known to be a specific finding in narcoleptic patients, the relationships between the severity of the core symptoms of narcolepsy [i.e. daytime sleepiness and increased rapid eye movement (REM) propensity], as well as levels of obesity, and CSF-orexin levels have not been well elucidated. The aim of this study was to ...
Known for Csf Orexin | Sleep Latency | Narcolepsy Cataplexy | Narcoleptic Patients
KOL-Index: 8541 . BACKGROUND: Causative role of encephalitis in major psychotic features, dyskinesias (particularly orofacial), seizures, and autonomic and respiratory changes has been recently emphasized. These symptoms often occur in young females with ovarian teratomas and are frequently associated with serum and CSF autoantibodies to the NMDA receptor (NMDAR). METHODS: The study included a total of 61 ...
Known for Patients Schizophrenia | Receptor Antibody | Psychotic Features | Nmdar Encephalitis
KOL-Index: 7622 . Narcolepsy is a chronic sleep disorder, characterized by excessive daytime sleepiness (EDS), cataplexy, sleep paralysis and hypnagogic hallucinations. Both sporadic (95%) and familial (5%) forms of narcolepsy exist in humans. The major pathophysiology of human narcolepsy has been recently discovered based on the discovery of narcolepsy genes in animals; the genes involved in the pathology ...
Known for Narcolepsy Cataplexy | Signaling Peptides | Hypocretin Orexin | Hypnagogic Hallucinations
KOL-Index: 7588 . We measured cerebrospinal fluid (CSF) hypocretin-1 levels in 11 patients with narcolepsy-cataplexy, five with narcolepsy without cataplexy and 12 with idiopathic hypersomnia (IHS). All patients were Japanese. As reported in Caucasian patients, undetectable or very low hypocretin-1 levels were observed in most (9 out of 11) Japanese narcolepsy--cataplexy patients. Our hypocretin-deficient ...
Known for Idiopathic Hypersomnia | Narcolepsy Cataplexy | Low Csf | Signaling Peptides
KOL-Index: 7560 . The therapeutic potential of thyrotropin-releasing hormone (TRH) and TRH analogs in narcolepsy, a sleep disorder characterized by abnormal rapid eye movement (REM) sleep and daytime sleepiness, was examined using the canine model. The effects of TRH and the biologically stable TRH analogs CG3703, CG3509, and TA0910 on daytime sleep and cataplexy, a symptom of abnormal REM sleep, were ...
Known for Canine Narcolepsy | Daytime Sleepiness | Releasing Hormone | Trh Analogs
KOL-Index: 7464 . In a double-blind cross-over study, seven athletes received zolpidem (10mg) or placebo in two sessions over two nights. Residual effects on subsequent daytime functions were evaluated objectively by measuring psychomotor and physical performance using a combined test of finger dexterity, a simple discriminatory reaction test, critical flicker fusion test (CFF), vertical jump, and 50-m ...
Known for Physical Performance | Placebo Zolpidem | Hypnotics Sedatives | Residual Effects
KOL-Index: 6342 . STUDY OBJECTIVES: Cyclic alternating pattern (CAP) is frequently followed by changes in heart rate (HR) and blood pressure (BP), but the sequential associations between CAP and autonomic nerve activity have not been studied. The study aimed to reveal the precise changes in heart rate variability (HRV) during phase A of the CAP cycle. DESIGN: Polysomnography was recorded according to the ...
Known for Heart Rate | Cyclic Alternating Pattern | Onset Phase | Autonomic Activity
KOL-Index: 6326 . OBJECTIVE: To characterize factors that contribute to symptomatic narcolepsy and excessive daytime sleepiness in neuromyelitis optica and multiple sclerosis. SETTING: Japanese university hospitals. DESIGN: Case study. PATIENTS: Seven Japanese patients whose initial diagnoses were multiple sclerosis and who were exhibiting excessive daytime sleepiness. MAIN OUTCOME MEASURES: Lesions on ...
Known for Neuromyelitis Optica | Symptomatic Narcolepsy | Multiple Sclerosis | Excessive Daytime Sleepiness

Key People For Cerebrospinal Fluid

Top KOLs in the world
#1
Kristina Blennow
cerebrospinal fluid alzheimer disease csf biomarkers
#2
Zetterberg Zetterberg
cerebrospinal fluid alzheimer disease csf biomarkers
#3
John Q Trojanowski
alzheimer disease lewy bodies tau pathology
#4
Philip K Scheltens⁎
alzheimer disease cognitive decline white matter
#5
Hans Link
multiple sclerosis myasthenia gravis dendritic cells
#6
Lennart Minthon
alzheimer disease cerebrospinal fluid lewy bodies

International Institute for Integrative Sleep Medicine, University of Tsukuba, Tsukuba, Japan | International Institute for Integrative Sleep Medicine (WPI‐IIIS), University of Tsukuba, Tsukuba, Japan | International Institute for Integrative Sleep M